[2026 update] Documenting an adverse event properly

Documenting an adverse event properly Writing it up because I had to work it out twice and would rather nobody else did.

Asking about Documenting an adverse event on behalf of the question I keep seeing asked badly, including by me.

Framed properly it is answerable. Framed the usual way it is not, and that is most of why the previous threads went nowhere.

Trying to state the Documenting an adverse event position in a way that someone who disagrees would recognise as fair, because I do not think the version in this thread passes that test.

Everything in the opening post holds. The case it does not cover is the one I have.

Medullary thyroid carcinoma is the reason these compounds are contraindicated in people with personal or family history of MTC or multiple endocrine neoplasia type 2. Rodent toxicology showed a signal; human evidence of causation is absent but caution is appropriate.

I would put the burden of proof on the interesting explanation, not the dull one.

Narrowing the opening post, because the general version has more than one answer.

Where to report: in many countries there is a pharmacovigilance system where adverse events can be reported. FDA MedWatch in the US, Yellow Card in UK, EudraVigilance in EU.

A single observation, in a thread that deserves better than single observations.

The opening post and I disagree about the size of the effect, not about the direction.

Psychological adverse events: mood changes, anxiety, or suicidal ideation warrant discussion with a mental health professional. These are rare but real.

The answer changed when I changed how I was measuring, which was informative.

The strongest argument against my own position on Documenting an adverse event, stated as well as I can state it, since nobody else has yet.

I had read the opposite somewhere and cannot now find where, which tells me something.

Post #5 answers the question as asked. The question underneath it is different.

Documenting an adverse event would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.

Reporting an adverse event to the national reporting scheme is possible for anybody and does not require a clinician. Those schemes exist to catch what trials could not.

That holds for the case as described. Change the assumptions and it may not.

This follows post #9 rather than contradicting it.

Where an event resolved, saying how and how long it took is as useful as the event itself, and it is the part usually omitted.

I would be interested in a counterexample if anyone has one.

Building on post #10 rather than restating it.

The reason Documenting an adverse event is hard to answer is that the obvious measurement and the relevant quantity are not the same thing, and substituting one for the other is silent.

Post #8 put the caveat in the right place and I want to underline it.

Attribution is genuinely hard for a single case and the reporting schemes are designed to work with that. You are not expected to prove causation to file.

Practical experience of Documenting an adverse event, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

Helpful, and short, which on this subject is harder than long.